MARKET

HOWL

HOWL

Werewolf Therapeutics, Inc.
NASDAQ
0.3200
-0.0204
-5.99%
After Hours: 0.3228 +0.0028 +0.88% 17:39 07/06 EDT
OPEN
0.3370
PREV CLOSE
0.3404
HIGH
0.3500
LOW
0.3128
VOLUME
572.13K
TURNOVER
--
52 WEEK HIGH
2.380
52 WEEK LOW
0.2700
MARKET CAP
15.55M
P/E (TTM)
-0.2647
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HOWL last week (0629-0703)?
Weekly Report · 12h ago
Werewolf Therapeutics director Luke Evnin disposes of 157,084 common shares for $47,125.2
PUBT · 6d ago
Weekly Report: what happened at HOWL last week (0622-0626)?
Weekly Report · 06/29 09:44
Major Investor Makes Bold Exit Move From Werewolf Therapeutics
TipRanks · 06/23 02:02
RA Capital Management disposes of Werewolf Therapeutics shares worth $145,069
PUBT · 06/22 23:00
Weekly Report: what happened at HOWL last week (0615-0619)?
Weekly Report · 06/22 09:49
Major Investor Quietly Unloads a Chunk of Werewolf Therapeutics Stock
TipRanks · 06/17 02:07
RA Capital Management disposes of $179,430 in Werewolf Therapeutics common shares
PUBT · 06/16 22:01
More
About HOWL
Werewolf Therapeutics, Inc. is a biopharmaceutical company engaged in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging its PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. The Company’s advanced clinical-stage product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2) and IL-12 INDUKINE molecules for the treatment of solid tumors. It is advancing WTX-124 in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor. It is advancing WTX-712, WTX-518, and WTX-921 through preclinical development.

Webull offers Werewolf Therapeutics Inc stock information, including NASDAQ: HOWL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HOWL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HOWL stock methods without spending real money on the virtual paper trading platform.